Back

Discovery of small molecule antagonists of human Retinoblastoma Binding Protein 4 (RBBP4)

Perveen, S.; Zepeda-Velazquez, C. A.; McLeod, D.; Marcellus, R.; Mohammed, M.; Abbey, M.; Ensan, D.; Panagopoulos, D.; Trush, V.; Gibson, E.; Dong, A.; Halabelian, L.; Poda, G.; Owen, J.; Aman, A.; Kiyota, T.; Mamai, A.; Arrowsmith, C. H.; Brown, P. J.; Schapira, M.; Al-awar, R.; Vedadi, M.

2022-01-05 biochemistry
10.1101/2022.01.05.475077 bioRxiv
Show abstract

RBBP4 is a nuclear WD40 motif-containing protein widely implicated in various cancers and a putative drug target. It interacts with multiple proteins within diverse complexes such as nucleosome remodeling and deacetylase (NuRD) complex and polycomb repressive complex 2 (PRC2), as well as histone H3 and H4 through two distinct binding sites. B-cell lymphoma/leukemia 11A (BCL11A), friend of GATA-1 (FOG-1), plant homeodomain finger protein 6 (PHF6) and histone H3 bind to the top of the donut-shaped seven-bladed {beta}-propeller fold of RBBP4, while suppressor of zeste 12 (SUZ12), metastasis associated protein 1 (MTA1) and histone H4 bind to a pocket on the side of the WD40 repeats of this protein. Here, we report the discovery of the first small molecule antagonists of the RBBP4 top pocket, competing with interacting peptides from proteins such as BCL11A and histone H3. We also determined the first crystal structure of RBBP4 in complex with a small molecule (OICR17251), paving the path for structure-guided design and optimization towards more potent antagonists.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.